CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
This Document Has Been Replaced By: Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 : Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Superseded
This Document Has Been Replaced By: Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 : Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
-
May 22, 1998
-
-
Source: MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1998; 47(RR-8):1-57.
Details:
-
Journal Article:Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
-
Personal Author:
-
Corporate Authors:
-
Description:These revised recommendations of the Advisory Committee on Immunization Practices (ACIP) on measles, mumps, and rubella prevention supersede recommendations published in 1989 and 1990. This statement summarizes the goals and current strategies for measles, rubella, and congenital rubella syndrome (CRS) elimination and for mumps reduction in the United States. Changes from previous recommendations include: Emphasis on the use of combined MMR vaccine for most indications; A change in the recommended age for routine vaccination to 12-15 months for the first dose of MMR, and to 4-6 years for the second dose of MMR; A recommendation that all states take immediate steps to implement a two dose MMR requirement for school entry and any additional measures needed to ensure that all school-aged children are vaccinated with two doses of MMR by 2001; A clarification of the role of serologic screening to determine immunity; A change in the criteria for determining acceptable evidence of rubella immunity; A recommendation that all persons who work in health-care facilities have acceptable evidence of measles and rubella immunity; Changes in the recommended interval between administration of immune globulin and measles vaccination; and Updated information on adverse events and contraindications, particularly for persons with severe HIV infection, persons with a history of egg allergy or gelatin allergy, persons with a history of thrombocytopenia, and persons receiving steroid therapy.
-
Subjects:
-
Source:
-
Series:
-
ISSN:1057-5987 (print);1545-8601 (digital);
-
Pubmed ID:9639369
-
Document Type:
-
Pages in Document:57 pdf pages
-
Volume:47
-
Issue:8
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
[PDF-564.79 KB]